Topics in Regulatory Economics and Policy Series, 20
یادداشتهای مربوط به مندرجات
متن يادداشت
Preface. 1. Introduction; T.A. Abbott III. Part I: Health Care Reform. 2. Lessons from Public Utility Regulation for the Economic Regulation of Health Care Markets: an Overview; T.A. Abbott III, M.A. Crew. Comments; W. Greenberg, G. Liss. 3. Regulatory Strategies under Managed Competition Health Care Reforms; M. Schlesinger. Comments. 4. Health Care Cost Containment in Connecticut; L.S. Cain. 5. Health Care Reform in New Jersey; P.S. Dickson. 6. Health Security Act: Summary and Impact; R. Rouse, P. Vernon, L. Stackman, K. Servis. Part II: Price Regulation. 7. Regulating Pharmaceutical Prices; T.A. Abbott III. Comments; A. Keith. 8. Hospital Price Regulation: Evidence and Implications for Health Care Reform; J. Hadley. 9. Paying Physicians as Agents: Fee-for-Service, Caption, or Hybrids? M.V. Pauly. Comments; B.E. Manning, D.W. Lee. Part III: Quality Regulation. 10. Medical Practice Guidelines and the Efficient Allocation of Resources; J.A. Rizzo, J.L. Sindelar. Comments; K.A. Weis. 11. Contending Views of Quality Management in Health Care: Implications for Competition and Regulation; H. Blumenthal, R. Bohmer. Comments; M.G. Coblentz, M. Gaynor. 12. Measuring and Improving Quality in Health Care; M.R. Chassin. Comments; J.F. Burgess Jr., P.M. Schyve. Glossary.
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
Part II: Price Regulation The second partofthis volume examines the role ofprice regulation in controlling health care costs. First, is there a clear need for price regulation, and second, can price regulation work in this industry?
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Economic policy.
موضوع مستند نشده
Economics.
موضوع مستند نشده
Public health.
رده بندی کنگره
شماره رده
RA395
.
A3
نشانه اثر
E358
1995
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )